Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes

15Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Williams-Beuren syndrome (WBS), an autosomal dominant genetic disorder, is characterized by a unique cognitive profile and craniofacial defects. WBS results from a microdeletion at the chromosomal location 7q11.23 that encompasses the genes encoding the members of TFII-I family of transcription factors. Given that the haploinsufficiency for TFII-I is causative to the craniofacial phenotype in humans, we set out to analyze the effect of post-transcriptional silencing of TFII-I during BMP-2- driven osteoblast differentiation in the C2C12 cell line. Our results show that TFII-I plays an inhibitory role in regulating genes that are essential in osteogenesis and intersects with the bone-specific transcription factor Runx2 and the retinoblastoma protein, pRb. Identification of pathways regulated by TFII-I family transcription factors may begin to shed light on the molecular determinants of WBS. © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Lazebnik, M. B., Tussie-Luna, M. I., Hinds, P. W., & Roy, A. L. (2009). Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes. Journal of Biological Chemistry, 284(52), 36234–36239. https://doi.org/10.1074/jbc.C109.063115

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free